World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
66
Citations
37463
World Ranking
2333
National Ranking
198

Overview

Saul N. Faust is affiliated with University Hospital Southampton NHS Foundation Trust in the United Kingdom. Their research primarily centers on medicine, with a strong focus on infectious diseases.

The scientist has contributed extensively to the study of COVID-19 and related respiratory illnesses. Their recent publications include key works such as Dexamethasone in Hospitalized Patients with Covid-19 (2020, DiRROS repository, University of Maribor), Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK (2020, The Lancet), and Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial (2020, The Lancet). Other notable papers include Effect of Hydroxychloroquine in Hospitalized Patients with Covid-19 (2020, New England Journal of Medicine) and Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials (2021, The Lancet).

Their most frequent coauthors include Christopher Green, Matthew D. Snape, Parvinder K. Aley, Teresa Lambe, and Adam Finn, reflecting established collaborative efforts in their fields of study.

Saul N. Faust's frequent publication venues reveal a concentration of scientific output in journals such as bioRxiv (Cold Spring Harbor Laboratory), SSRN Electronic Journal, Journal of Infection, The Lancet, and The Lancet Child & Adolescent Health.

Their main fields of study encompass medicine broadly, with significant engagement in subfields including infectious diseases, epidemiology, surgery, pulmonary and respiratory medicine, and neurology.

Key research topics covered by their work are:

  • SARS-CoV-2 and COVID-19 Research
  • COVID-19 Clinical Research Studies
  • Pneumonia and Respiratory Infections
  • Respiratory viral infections research
  • Vaccine Coverage and Hesitancy
  • Long-Term Effects of COVID-19
  • Bacterial Infections and Vaccines

Best Publications

  • Dexamethasone in Hospitalized Patients with Covid-19

    P Horby;W S Lim;Emberson

  • Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK.

    M Voysey;Clemens Sac.;S A Madhi;L Y Weckx

  • Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial

    P M Folegatti;K J Ewer;P K Aley;B Angus

  • Surviving Sepsis Campaign International Guidelines for the Management of Septic Shock and Sepsis-Associated Organ Dysfunction in Children

    Scott L. Weiss;Mark J. Peters;Waleed Alhazzani;Michael S.D. Agus

  • Effect of Hydroxychloroquine in Hospitalized Patients with Covid-19

    P Horby;M Mafham;L Linsell

  • Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials.

    M Voysey;S A Costa Clemens;S A Madhi;L Y Weckx

  • Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial.

    M N Ramasamy;A M Minassian;K J Ewer;A L Flaxman

  • Dysfunction of Endothelial Protein C Activation in Severe Meningococcal Sepsis

    Saul N. Faust;Michael Levin;Odile B. Harrison;Robert D. Goldin

  • Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial

    Pedro M Folegatti;Katie J Ewer;Parvinder K Aley;Brian Angus

  • Effect of Dexamethasone in Hospitalized Patients with COVID-19 – Preliminary Report

    P Horby;W S Lim;J Emberson;M Mafham

  • Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B.1.1.7): an exploratory analysis of a randomised controlled trial.

    Katherine R W Emary;Tanya Golubchik;Parvinder K Aley;Cristina V Ariani

  • Lopinavir–ritonavir in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

    Peter W Horby;Marion Mafham;Jennifer L Bell;Louise Linsell

  • Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

    P W Horby;M Campbell;E Spata;Emberson

  • Safety and immunogenicity of heterologous versus homologous prime-boost schedules with an adenoviral vectored and mRNA COVID-19 vaccine (Com-COV): a single-blind, randomised, non-inferiority trial.

    Xinxue Liu;Robert H Shaw;Arabella S V Stuart;Melanie Greenland

  • Clinical spectrum and features of activated phosphoinositide 3-kinase δ syndrome: A large patient cohort study.

    Tanya I Coulter;Anita Chandra;Chris M Bacon;Judith Babar

  • Safety and immunogenicity of seven COVID-19 vaccines as a third dose (booster) following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK (COV-BOOST): a blinded, multicentre, randomised, controlled, phase 2 trial

    Alasdair P S Munro;Alasdair P S Munro;Leila Janani;Victoria Cornelius;Parvinder K Aley

  • A national consensus management pathway for paediatric inflammatory multisystem syndrome temporally associated with COVID-19 (PIMS-TS): results of a national Delphi process.

    Rachel Harwood;Benjamin Allin;Christine E Jones;Elizabeth Whittaker

  • Diagnostic test accuracy of a 2-transcript host RNA signature for discriminating bacterial vs viral infection in febrile children

    Jethro A. Herberg;Myrsini Kaforou;Victoria J. Wright;Hannah Shailes

  • Effect of a quadrivalent meningococcal ACWY glycoconjugate or a serogroup B meningococcal vaccine on meningococcal carriage: an observer-blind, phase 3 randomised clinical trial

    Robert C Read;David Baxter;David R Chadwick;Saul N Faust;Saul N Faust

  • Preliminary Assessment of the Efficacy of a T-Cell–Based Influenza Vaccine, MVA-NP+M1, in Humans

    Patrick J. Lillie;Tamara K. Berthoud;Timothy J. Powell;Teresa Lambe

  • Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

    P Horby;M Mafham;L Peto

  • Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

    Peter W Horby;Lise Estcourt;Leon Peto

Frequent Co-Authors

Stuart C. Clarke
Stuart C. Clarke University of Southampton
Adam Finn
Adam Finn University of Bristol
Andrew J. Pollard
Andrew J. Pollard University of Oxford
Matthew D. Snape
Matthew D. Snape University of Oxford
Paul T. Heath
Paul T. Heath St George's, University of London
Michael Levin
Michael Levin Tufts University
Jeremy S. Webb
Jeremy S. Webb University of Southampton
Luanne Hall-Stoodley
Luanne Hall-Stoodley The Ohio State University
Sarah C. Gilbert
Sarah C. Gilbert University of Oxford
Katie J. Ewer
Katie J. Ewer University of Oxford

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Microbiology in the USA opens doors to various dynamic healthcare careers beyond traditional lab roles. For those interested in blending clinical knowledge with patient-centered care, exploring the functional medicine nurse salary reveals promising opportunities in holistic healthcare settings.

With the increasing reliance on electronic health records and data management, jobs like Certified Professional Coder are critical. Learning about the certified professional coder pathway can provide a stable career linking medical knowledge and administrative skills.

Health Information Management offers another rewarding avenue, especially for those who excel in organizing and safeguarding medical data. Entry-level roles in this field are well-compensated, making the health information management salary entry-level insight useful for new graduates.

Considering an online degree? Several programs stand out for quality education and industry recognition. You can explore options through the best online cahiim accredited health information management degree programs to advance your career while studying remotely.

Best Scientists Citing Saul N. Faust

Trending Scientists